SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 39.65 |
Enterprise Value ($M) | 24.53 |
Book Value ($M) | 14.05 |
Book Value / Share | 1.58 |
Price / Book | 2.82 |
NCAV ($M) | 14.05 |
NCAV / Share | 1.58 |
Price / NCAV | 2.82 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.59 |
Return on Assets (ROA) | -0.24 |
Return on Equity (ROE) | -0.42 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.57 |
Current Ratio | 5.57 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 17.13 |
Assets | 17.13 |
Liabilities | 3.07 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 3.31 |
Operating Income | -14.58 |
Net Income | -8.24 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -16.44 |
Cash from Investing | 18.66 |
Cash from Financing | 1.11 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Aisling Capital IV, LP | 5.46 | -86.73 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,348 | 19,494 | 6.91 | |
1,300 | 15,856 | 8.20 | |
5,466 | 45,149 | 12.11 | |
1,534 | 10,955 | 14.00 | |
(click for more detail) |
Similar Companies | |
---|---|
MIRA – MIRA Pharmaceuticals, Inc. | MLTX – MoonLake Immunotherapeutics |
MNPR – Monopar Therapeutics Inc. | MTEM – Molecular Templates, Inc. |
MYMD – MyMD Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io